Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fiona Lalloo

Showing results (71-80 of 162) with videos related to

Pageof 17
Sort By:
International Journal of Cancer|September 19, 2002
Survival in prospectively ascertained familial breast cancer: analysis of a series stratified by tumour characteristics, BRCA mutations and oophorectomyPål Møller, Ake Borg, D Gareth Evans, et al.
International Journal of Cancer|November 5, 2020
Specialist oncological surgery for removal of the ovaries and fallopian tubes in BRCA1 and BRCA2 pathogenic variant carriers may reduce primary peritoneal cancer risk to very low levelsEmma J Crosbie, Nicola Flaum, Elaine F Harkness, et al.
Journal of Medical Genetics|January 16, 2021
Advances in genetic technologies result in improved diagnosis of mismatch repair deficiency in colorectal and endometrial cancersD Gareth Evans, Fiona Lalloo, Neil Aj Ryan, et al.
Gut|November 30, 2019
Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG)Kevin J Monahan, Nicola Bradshaw, Sunil Dolwani, et al.
European Urology Oncology|December 14, 2019
Hereditary Leiomyomatosis and Renal Cell Cancer: Clinical, Molecular, and Screening Features in a Cohort of 185 Affected IndividualsClaire Forde, Derek H K Lim, Yousef Alwan, et al.
Clinical Endocrinology|February 21, 2004
Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibilityDewi Astuti, Niki Hart-Holden, Farida Latif, et al.
Journal of Medical Genetics|September 18, 2017
CNVs affecting cancer predisposing genes (CPGs) detected as incidental findings in routine germline diagnostic chromosomal microarray (CMA) testingJosie Innes, Lisa Reali, Jill Clayton-Smith, et al.
Cancers|August 27, 2021
Gene Panel Testing for Breast Cancer Reveals Differential Effect of Prior <i>BRCA1/2</i> ProbabilityD Gareth Evans, Elke M van Veen, Emma R Woodward, et al.
Breast Cancer Research and Treatment|July 27, 2021
Breast cancer incidence and early diagnosis in a family history risk and prevention clinic: 33-year experience in 14,311 womenD Gareth Evans, Sacha J Howell, Ashu Gandhi, et al.
Journal of Medical Genetics|May 11, 2025
UK clinical practice guidelines for the management of patients with constitutional <i>POT1</i> pathogenic variantsOlga Tsoulaki, D Gareth Evans, Khushboo Sinha, et al.
Pageof 17

Showing results (71-80 of 162) with videos related to

Sort By:
Pageof 17
International Journal of Cancer|September 19, 2002
Survival in prospectively ascertained familial breast cancer: analysis of a series stratified by tumour characteristics, BRCA mutations and oophorectomyPål Møller, Ake Borg, D Gareth Evans, et al.
International Journal of Cancer|November 5, 2020
Specialist oncological surgery for removal of the ovaries and fallopian tubes in BRCA1 and BRCA2 pathogenic variant carriers may reduce primary peritoneal cancer risk to very low levelsEmma J Crosbie, Nicola Flaum, Elaine F Harkness, et al.
Journal of Medical Genetics|January 16, 2021
Advances in genetic technologies result in improved diagnosis of mismatch repair deficiency in colorectal and endometrial cancersD Gareth Evans, Fiona Lalloo, Neil Aj Ryan, et al.
Gut|November 30, 2019
Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG)Kevin J Monahan, Nicola Bradshaw, Sunil Dolwani, et al.
European Urology Oncology|December 14, 2019
Hereditary Leiomyomatosis and Renal Cell Cancer: Clinical, Molecular, and Screening Features in a Cohort of 185 Affected IndividualsClaire Forde, Derek H K Lim, Yousef Alwan, et al.
Clinical Endocrinology|February 21, 2004
Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibilityDewi Astuti, Niki Hart-Holden, Farida Latif, et al.
Journal of Medical Genetics|September 18, 2017
CNVs affecting cancer predisposing genes (CPGs) detected as incidental findings in routine germline diagnostic chromosomal microarray (CMA) testingJosie Innes, Lisa Reali, Jill Clayton-Smith, et al.
Cancers|August 27, 2021
Gene Panel Testing for Breast Cancer Reveals Differential Effect of Prior <i>BRCA1/2</i> ProbabilityD Gareth Evans, Elke M van Veen, Emma R Woodward, et al.
Breast Cancer Research and Treatment|July 27, 2021
Breast cancer incidence and early diagnosis in a family history risk and prevention clinic: 33-year experience in 14,311 womenD Gareth Evans, Sacha J Howell, Ashu Gandhi, et al.
Journal of Medical Genetics|May 11, 2025
UK clinical practice guidelines for the management of patients with constitutional <i>POT1</i> pathogenic variantsOlga Tsoulaki, D Gareth Evans, Khushboo Sinha, et al.
Pageof 17